Salmeterol (as Xinafoate) + Fluticasone Propionate -DRP-7394

Main information

  • Trade name:
  • Salmeterol (as Xinafoate) + Fluticasone Propionate -DRP-7394 50 mcg/ 500 mcg Powder for Inhalation
  • Dosage:
  • 50 mcg/ 500 mcg
  • Pharmaceutical form:
  • Powder for Inhalation
  • Units in package:
  • PA/ ALu/ PVC Blister in dry inhalation device, Aluminum pouched x 60 pre-metered doses (Box of 1's)
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug
  • Manufactured by:
  • Aeropharm GmbH

Documents

Localization

  • Available in:
  • Salmeterol (as Xinafoate) + Fluticasone Propionate -DRP-7394 50 mcg/500 mcg Powder for Inhalation
    Philippines
  • Language:
  • English

Status

  • Source:
  • FDA - Food And Drug Administration - Philippines
  • Authorization number:
  • DRP-7394
  • Authorization date:
  • 05-10-2022
  • Last update:
  • 16-01-2018